The TNF superfamily in 2009: new pathways, new indications, and new drugs
- 1 December 2009
- journal article
- Published by Elsevier BV in Drug Discovery Today
- Vol. 14 (23-24), 1082-1088
- https://doi.org/10.1016/j.drudis.2009.10.002
Abstract
No abstract availableKeywords
This publication has 50 references indexed in Scilit:
- An essential role for transmembrane TNF in the resolution of the inflammatory lesion induced by Leishmania major infectionEuropean Journal of Immunology, 2008
- Billion dollar babies—biotech drugs as blockbustersNature Biotechnology, 2007
- Isolated Limb Perfusion With Melphalan and Tumor Necrosis Factor α for Advanced Melanoma and Soft-Tissue SarcomaAnnals of Surgical Oncology, 2006
- Transmembrane TNF protects mutant mice against intracellular bacterial infections, chronic inflammation and autoimmunityEuropean Journal of Immunology, 2006
- Membrane TNF confers protection to acute mycobacterial infectionRespiratory Research, 2005
- Contribution of Transmembrane Tumor Necrosis Factor to Host Defense against Mycobacterium bovis Bacillus Calmette-Guerin and Mycobacterium tuberculosis InfectionsThe American Journal of Pathology, 2005
- Transmembrane TNF Is Sufficient to Initiate Cell Migration and Granuloma Formation and Provide Acute, but Not Long-Term, Control ofMycobacterium tuberculosisInfectionThe Journal of Immunology, 2005
- TNF neutralization in MSNeurology, 1999
- Treatment of Septic Shock with the Tumor Necrosis Factor Receptor:Fc Fusion ProteinNew England Journal of Medicine, 1996
- Human tumour necrosis factor: precursor structure, expression and homology to lymphotoxinNature, 1984